June 14, 2021, 1:30 p.m.

IPO Brief - Week #24 (15 companies are going public this week)

IPO Brief

Good morning. 15 companies are planned to go public this week (14 Jun - 18 Jun)

CNVY Convey Holding Parent 2003

Software & Tech Services • 13,333,334 shares • $14.00 - $16.00 • NYSE

Convey Health is a provider of end to end member enrollment, service, administration and wellness solutions for our carrier and PBM clients.

Website SEC Bloomberg Crunchbase
Notify me when $CNVY goes public The expected IPO date is Wednesday, June 16th, 2021

MOLN Molecular Partners 2004

Biotech & Pharma • 3,000,000 shares • $27.14 • Nasdaq

$188.8M total funding amount

Molecular Partners is a clinical-stage biopharmaceutical company.

Website SEC Bloomberg Crunchbase
Notify me when $MOLN goes public The expected IPO date is Wednesday, June 16th, 2021

WKME WalkMe 2011

Software & Tech Services • 9,250,000 shares • $29.00 - $32.00 • Nasdaq

Series G • $307.5M total funding amount

WalkMe's digital adoption platform enables organizations to measure, drive, and act to maximize the impact of their digital transformation.

Website SEC Bloomberg Crunchbase
Notify me when $WKME goes public The expected IPO date is Wednesday, June 16th, 2021

AOMR Angel Oak Mortgage 2013

Real Estate • 8,050,000 shares • $20.00 - $21.00 • NYSE

Angel Oak Mortgage Solutions is a financial services company that provides mortgage solutions.

Website SEC Bloomberg Crunchbase
Notify me when $AOMR goes public The expected IPO date is Thursday, June 17th, 2021

UNCY Unicycive Therapeutics 2016

Biotech & Pharma • 2,635,000 shares • $8.50 - $10.50 • Nasdaq

Series A • $6M total funding amount

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with significant unmet medical needs.

Website SEC Bloomberg Crunchbase
Notify me when $UNCY goes public The expected IPO date is Thursday, June 17th, 2021

LYEL Lyell Immunopharma 2018

Biotech & Pharma • 25,000,000 shares • $16.00 - $18.00 • Nasdaq

Series C • $493M total funding amount

Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.

Website SEC Bloomberg Crunchbase
Notify me when $LYEL goes public The expected IPO date is Thursday, June 17th, 2021

RERE AiHuiShou International 2009 🦄

Retail & Whsle - Discretionary • 16,233,000 shares • $13.00 - $15.00 • NYSE

Series E • $877.6M total funding amount

Aihuishou is a bidding-based C2B platform for recycling and selling second-hand electronic items such as mobile phones.

Website SEC Bloomberg Crunchbase
Notify me when $RERE goes public

ATAI ATAI Life Sciences 2018 🦄

Biotech & Pharma • 14,286,000 shares • $13.00 - $15.00 • Nasdaq

$347.1M total funding amount

ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.

Website SEC Bloomberg Crunchbase
Notify me when $ATAI goes public

IPSC Century Therapeutics 2018 🦄

Biotech & Pharma • 10,550,000 shares • $18.00 - $20.00 • Nasdaq

Series C • $410M total funding amount

Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.

Website SEC Bloomberg Crunchbase
Notify me when $IPSC goes public

CYT Cyteir Therapeutics 2012

Biotech & Pharma • 7,400,000 shares • $16.00 - $18.00 • Nasdaq

Series C • $156.7M total funding amount

Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.

Website SEC Bloomberg Crunchbase
Notify me when $CYT goes public

AMAM Ambrx Biopharma 2003

Biotech & Pharma • 7,000,000 shares • $17.00 - $19.00 • NYSE

$347.9M total funding amount

Ambrx develops protein therapeutics that preserve potency, reduce dosing frequency, and improve homogeneity of the drug substance.

Website SEC Bloomberg Crunchbase
Notify me when $AMAM goes public

DNAY Codex DNA 2013

Biotech & Pharma • 6,666,665 shares • $14.00 - $16.00 • Nasdaq

Series A • $25M total funding amount

Codex DNA empowers researchers with the tools they need to rapidly and securely design, code, and create synthetic DNA.

Website SEC Bloomberg Crunchbase
Notify me when $DNAY goes public

VERV Verve Therapeutics 2018

Biotech & Pharma • 11,800,000 shares • $16.00 - $18.00 • Nasdaq

Series B • $215.5M total funding amount

Verve is focused on discovering and developing therapies that safely edit the genomes of adults to confer protection against coronary.

Website SEC Bloomberg Crunchbase
Notify me when $VERV goes public

FEMY Femasys 2004

Medical Equipment & Devices • 2,650,000 shares • $12.00 - $14.00 • Nasdaq

$63.9M total funding amount

Femasys engages in R&D and manufacture of medical devices for women's healthcare.

Website SEC Bloomberg Crunchbase
Notify me when $FEMY goes public

HKD AMTD Digital 2019

Software & Tech Services • 16,000,000 shares • $6.80 - $8.20 • NYSE

AMTD Digital Inc. provides software solutions. The Company develops digital solutions platforms in Asia with businesses spanning multiple verticals, including digital financial services, digital media, content, marketing, and digital investments.

SEC Bloomberg Crunchbase
Notify me when $HKD goes public

Want to show up as a sponsor and support the IPO Brief? Contact us by replying to this email or check more information here.

If you have any questions or would like to see more information, just hit the reply button.

And please share it with friends using the links below:

IPO Brief • Twitter • Facebook • LinkedIn

You just read issue #45 of IPO Brief. You can also browse the full archives of this newsletter.

This email brought to you by Buttondown, the easiest way to start and grow your newsletter.